Pfizer falls 12 pct in Europe after key drug fails
448143
Shares in Pfizer Inc fell 12 percent in Europe on Monday after the world's biggest drugmaker scrapped development of its most important experimental medicine.
311418
Investors in pharmaceuticals were dealt  a triple whammy on Friday as Pfizer Inc, AstraZeneca Plc and  Eli Lilly and Co all shocked the market with bad news about key  products.
49327
Pfizer Inc.  shares  tumbled as much as 15.6 percent on Monday, wiping out nearly  $30 billion of market value, after the world's biggest drug  maker unexpectedly ended development of its most important  experimental medicine.
479171
NEW YORK  - Pfizer dismissed a report on the safety of its pain reliever Bextra, but the new controversy weighed on the stock price of the US pharmaceutical giant.
414602
Stock falls on news treatment failed a mid-stage trial, company will cease developing drug. NEW YORK  - AtheroGenics Inc.
750028
Shares in Schering dropped on Friday  after the German drugmaker said U.S. regulators needed more  information to approve its key Bonefos drug for use in  preventing bone tumors in breast cancer patients.
22568
AstraZeneca Plc suffered its third  setback in two months on Friday as lung cancer drug Iressa  failed to help patients live longer in a major clinical trial,  sending its shares down as much as 9.2 percent.
624082
Pfizer Inc., the world&#39;s largest drugmaker, said third-quarter earnings jumped 49 percent after merger-related expenses fell and sales of the cholesterol treatment Lipitor rose.
685070
Pfizer Inc.  on Wednesday reported lower-than-expected quarterly earnings on competition with generics, and said global sales of cholesterol fighter Lipitor fell 13 percent amid slipping demand for the company's flagship product.
653549
Shares of Wyeth WYE.N and Pfizer  Inc. PFE.N fell on Monday after Merrill Lynch downgraded the  drugmakers and U.K. regulators issued tougher warnings on the  type of popular depression drugs sold by the companies.
714433
Shares of Wyeth  and Pfizer Inc.  fell on Monday after Merrill Lynch downgraded the drugmakers and U.K. regulators issued tougher warnings on the type of popular depression drugs sold by the companies.
505706
Global drugs giant Pfizer sees profits fall after a drop in worldwide sales of cholesterol drug Lipitor.
91858
NEW YORK/LONDON  - Shares of Pfizer Inc.  fell 15.6 percent in opening trade on Monday, wiping out nearly $30 billion of market value, after the world's biggest drugmaker scrapped development of its most important experimental medicine.
489823
Shares in Pfizer Inc, the world's biggest drugmaker, fell more than 10 percent in early trade in Europe on Monday, after news it had scrapped its most important experimental drug.
643296
NEW YORK  - Drugs giant Pfizer Inc.&#39;s stock fell on a report that prescriptions for its blockbuster pain medication Celebrex slumped 56 percent last week.
564654
Drugmaker Pfizer Inc. said Wednesday its second-quarter profit fell 48 percent year-over-year, hurt by the loss of patent exclusivity for its Zoloft and Norvasc drugs and by sluggish sales of blockbuster cholesterol drug, Lipitor, in the U.S.
723080
Pfizer loses a patent case over its top compound.